as 11-15-2024 4:00pm EST
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
Founded: | N/A | Country: | Canada |
Employees: | N/A | City: | NEW YORK |
Market Cap: | 1.5B | IPO Year: | 2018 |
Target Price: | $1.88 | AVG Volume (30 days): | 30.1M |
Analyst Decision: | Hold | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.27 | EPS Growth: | N/A |
52 Week Low/High: | $1.33 - $2.97 | Next Earning Date: | 01-07-2025 |
Revenue: | $812,037,000 | Revenue Growth: | 24.76% |
Revenue Growth (this year): | 18.31% | Revenue Growth (next year): | 5.26% |
TLRY Breaking Stock News: Dive into TLRY Ticker-Specific Updates for Smart Investing
Morningstar Research
2 days ago
GlobeNewswire
3 days ago
GlobeNewswire
3 days ago
GlobeNewswire
4 days ago
GlobeNewswire
4 days ago
GlobeNewswire
5 days ago
Morningstar Research
10 days ago
GlobeNewswire
10 days ago
The information presented on this page, "TLRY Tilray Brands Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.